Open access
Open access
Powered by Google Translator Translator

Daily Archives: February 23, 2017

Thu, Feb 23 – Top 10 Medical News Stories

23 Feb, 2017 | 00:01h | UTC

 

1 – Guidelines on hepatitis B and C testing – World Health Organization

See also: World Health Organization’s Global Hepatitis Programme web site

 

2 – News Release: WHO issues first viral hepatitis testing guidelines – World Health Organization

 

3 – Testosterone Therapy: Five New Reports Offer a Mixed Bag – Physician’s First Watch

Good summary of 5 reports just published in JAMA and JAMA Internal Medicine

 

4 – Editorial: Further Elucidation of the Potential Benefits of Testosterone Therapy in Older Men – JAMA Internal Medicine

 

5 – Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury – Kidney International

Source: Popular heartburn drugs linked to gradual yet ‘silent’ kidney damage – Medical Xpress

From related editorial ($) Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?Although the study does not prove causality, the robustness of the findings in two cohorts suggests a need for further study and reevaluation of the safety of these agents for widespread, non-prescription use”

 

6 – Drug misuse prevention: targeted interventions – NICE Guideline

News Release: Local authorities need to work together with nightclubs and gyms to prevent drug misuse

 

7 – Overdiagnosis Is a Problem in Pediatrics, Too: Abnormal test results pursued endlessly without a clinical benefit – MedPage Today (free registration required)

See also: Overdiagnosis, Overtreatment Too Common in Pediatric Care – Medscape (free registration required)

See also: Use of Low-Value Pediatric Services Among the Commercially Insured – Pediatrics (this open-access article has a list of 20 Low-Value Pediatric Services)

Original article abstract ($ required for full-text): Update on Pediatric Overuse – Pediatrics

 

8 – Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial – The Lancet

A single sigmoidoscopy between 55 and 64 years of age confers reduction in colorectal cancer incidence and mortality with long-term benefits

 

9 – Flexible sigmoidoscopy screening: is once enough? – The Lancet

 

10 – New screening test cuts bowel cancer risk by a third, study finds – The Guardian

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.